4.3 Article

Co-occurrence between hereditary angioedema and multiple sclerosis: Therapeutic management of both diseases with fingolimod

Related references

Note: Only part of the references are listed.
Article Allergy

Roles of Immune Cells in Hereditary Angioedema

Anne Lise Ferrara et al.

Summary: Hereditary angioedema is a rare genetic disease characterized by recurrent mucosal swelling, and can be classified into two types based on the level of C1-inhibitor activity. Recent evidence suggests that both innate and adaptive immune responses play important roles in the pathophysiology of angioedema, with various immune cells contributing to the process.

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2021)

Review Clinical Neurology

Multiple sclerosis - a review

R. Dobson et al.

EUROPEAN JOURNAL OF NEUROLOGY (2019)

Article Medicine, Research & Experimental

The complex alteration in the network of IL-17-type cytokines in patients with hereditary angioedema

Francesco Arcoleo et al.

CLINICAL AND EXPERIMENTAL MEDICINE (2018)

Review Medicine, General & Internal

Disease Severity, Activity, Impact, and Control and How to Assess Them in Patients with Hereditary Angioedema.

Anette Bygum et al.

FRONTIERS IN MEDICINE (2017)

Article Pathology

RGC-32 as a potential biomarker of relapse and response to treatment with glatiramer acetate in multiple sclerosis

Adam M. Kruszewski et al.

EXPERIMENTAL AND MOLECULAR PATHOLOGY (2015)

Article Neurosciences

Fingolimod Modulates Peripheral Effector and Regulatory T Cells in MS Patients

Laura D. Serpero et al.

JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2013)

Article Clinical Neurology

The mechanism of action of glatiramer acetate treatment in multiple sclerosis

Michael K. Racke et al.

NEUROLOGY (2010)

Article Medicine, General & Internal

Hereditary angioedema: New findings concerning symptoms, affected organs, and course

K Bork et al.

AMERICAN JOURNAL OF MEDICINE (2006)